AI steps in to help doctors spot Hard-to-See cancer clues
NCT ID NCT07274579
Summary
This study aims to create an artificial intelligence (AI) model to help analyze a specific protein (Claudin18.2) in digestive system cancers. It will use data from up to 2,000 patients to train and test the AI, comparing its accuracy to current manual methods. The goal is to make this type of cancer testing more consistent, objective, and efficient to better guide personalized treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIGESTIVE ONCOLOGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Qianfoshan Hospital
Jinan, Shandong, 250014, China
Conditions
Explore the condition pages connected to this study.